13F reference period
Q2 2026
Security Snapshot
Odyssey Therapeutics, Inc. - COMMON STOCK (ODTX) Institutional Ownership
CUSIP: 67613T104
13F Institutional Holders and Ownership History from Q2 2026 to Q3 2026
Institutions Reporting
59
Shares (Excl. Options)
34.89M
Full value: 34,894,074 · shares · 30 Jun 2026Price
$18.71
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- ODTX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 34,894,074
- Total 13F value
- $652,875,128
- Portfolio coverage rank
- 0%
- Share change
- +34,894,074
- Value change
- +$652,875,128
- Number of holders
- 59
- Shares outstanding
- 47,994,131
- SEC-reported price per share
- $18.26
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- ODTX - Odyssey Therapeutics, Inc. - COMMON STOCK is tracked under CUSIP 67613T104.
- 59 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- The headline uses Q2 2026 reported holdings.
- Quarter-over-quarter comparison is unavailable because the immediately preceding quarter is missing.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 59 institutions filings for Q2 2026.
Security key
67613T104
13F reference period
Q2 2026
13F holders
59
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
ODTX full holder history
Odyssey Therapeutics, Inc. SEC filings
Odyssey Therapeutics, Inc. company facts
Odyssey Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 67613T104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
ODTX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 13% | +28% | $113,928,468 | +$30,347,664 | 6,239,237 | +36% | FMR LLC | 30 Sep 2026 |
| SR ONE CAPITAL MANAGEMENT, LLC | 8% | $68,080,201 | 3,794,883 | SR One Capital Management, LLC | 11 May 2026 | |||
| TPG GP A, LLC | 7.8% | $66,201,219 | 3,690,146 | TPG GP A, LLC | 11 May 2026 | |||
| Jeito II S.L.P. | 7.8% | $66,201,201 | 3,690,145 | Jeito II S.L.P. | 08 May 2026 | |||
| Lightspeed Venture Partners XV-B (Ignite), L.P. | 7.6% | $64,735,467 | 3,608,443 | Lightspeed Venture Partners XV-B (Ignite), L.P. | 11 May 2026 | |||
| Dimension Capital II, L.P. | 7.1% | $59,803,277 | 3,333,516 | Dimension Capital II, L.P. | 08 May 2026 |
As of 30 Jun 2026,
59
institutional investors reported holding
shares of
Odyssey Therapeutics, Inc. - COMMON STOCK (ODTX).
This represents
73%
of the company’s total
outstanding shares.
34.89M
Full value: 34,894,074 · shares · 30 Jun 202647.99M
Full value: 47,994,131 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 11% | 5,179,262 | 0% | $96,903,992 | |
| SR One Capital Management, LP | 7.9% | 3,794,883 | 6.8% | $71,002,261 | |
| TPG GP A, LLC | 7.7% | 3,690,146 | 1.4% | $69,042,632 | |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 7.5% | 3,608,443 | 2.8% | $67,513,969 | |
| ORBIMED ADVISORS LLC | 6.3% | 3,001,198 | 1.1% | $56,152,415 | |
| Sanofi | 4.2% | 1,991,918 | 7% | $37,268,786 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.2% | 1,046,139 | 0.2% | $19,573,261 | |
| Sands Capital Alternatives, LLC | 1.8% | 875,000 | 2.7% | $16,371,250 | |
| HHLR ADVISORS, LTD. | 1.7% | 831,656 | 1.9% | $15,560,284 | |
| General Catalyst Group Management, LLC | 1.7% | 810,272 | 8% | $15,160,189 | |
| Affinity Asset Advisors, LLC | 1.6% | 766,346 | 0.7% | $14,338,334 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.5% | 725,000 | 0.02% | $13,564,750 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.5% | 720,440 | 0% | $13,479,432 | |
| Foresite Capital Management V, LLC | 1.5% | 713,105 | 3.7% | $13,342,195 | |
| Vivo Capital, LLC | 1.2% | 575,000 | 0.98% | $10,758,250 | |
| EcoR1 Capital, LLC | 1.2% | 555,555 | 0.52% | $10,394,434 | |
| Logos Global Management LP | 1.1% | 521,736 | 0.42% | $9,761,681 | |
| MARSHALL WACE, LLP | 1% | 492,697 | 0.01% | $9,218,361 | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.98% | 471,987 | 0% | $8,831,000 | |
| Catalio Capital Management, LP | 0.95% | 457,839 | 1.6% | $8,566,168 | |
| Redmile Group, LLC | 0.89% | 425,000 | 0.53% | $7,951,750 | |
| Balyasny Asset Management L.P. | 0.82% | 393,862 | 0.01% | $7,369,158 | |
| Woodline Partners LP | 0.72% | 345,746 | 0.02% | $6,468,908 | |
| FRANKLIN RESOURCES INC | 0.57% | 275,022 | 0% | $5,145,662 | |
| Boxer Capital Management, LLC | 0.57% | 275,000 | 0.39% | $5,145,250 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Headline period
Q2 2026
Rows shown
1-2 of 2